1. Market Overview

1.1 Arthritis
1.2 Types of Arthritis
1.2 Rheumatoid Arthritis
1.3 Causes
1.4 Stage
1.5 Diagnosis
1.6 Treatment Options

2 Global Market

2.1 Global Rheumatoid Arthritis Market by Value
2.2 Global Rheumatoid Arthritis Market by Drug Class
2.3 Global Rheumatoid Market Share by Drug
2.4 Global Rheumatoid Arthritis Market Share by Biologics

3. The U.S. Market

3.1 The US Rheumatoid Arthritis Market by Value
3.2 The US Rheumatoid Arthritis Patient Prevalence
3.3 The US Rheumatoid Arthritis Patient Penetration
3.4 The US Rheumatoid Arthritis Anti-TNF Population
3.5 The US Rheumatoid Arthritis Biologics Population

4. Market Dynamics

4.1 Key Trends

4.1.1 Increasing Competition from Anti-IL-6 Drugs
4.1.2 Rising FDA Approvals to Rheumatoid Arthritis Drugs
4.1.3 Auto-Injectors for Rheumatoid Arthritis
4.1.4 Use of Complementary and Alternative Medicines (CAMs)
4.1.5 Increasing Biosimilars for Rheumatoid Arthritis

4.2 Growth Drivers

4.2.1 Increasing Female Population Worldwide
4.2.2 Escalating Global Ageing Population
4.2.3 Rising Global Health Care Expenditure
4.2.4 Rising Cigarette Consumption
4.2.5 Increasing Obese Population

4.3 Challenges

4.3.1 High Cost of Treatment
4.3.3 High R&D Cost

5. Competitive Landscape

5.1 Global Market
5.1.1 Rheumatoid Arthritis Market Share by Company
5.1.2 Rheumatoid Arthritis Market Competition by Anti-TNF
5.1.3 Rheumatoid Arthritis Competition by Biologics
5.2 The US Market
5.2.1 Rheumatoid Arthritis Brand (Company) Share

6. Company Profiles

6.1 AbbVie

6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 Johnson & Johnson

6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 Amgen Inc.

6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 Pfizer Inc.

6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies


List of Charts

Types of Arthritis
Global Rheumatoid Arthritis Market by Value (2015-2020E)
Global Rheumatoid Arthritis Market by Drug Class (2015/2020E)
Global Rheumatoid Arthritis Market Share by Drug (2016E)
Global Rheumatoid Arthritis Market Share by Biologics (2015)
The US Rheumatoid Arthritis Market by Value (2015-2020E)
The US Rheumatoid Arthritis Patient Prevalence (2015-2020E)
The US Rheumatoid Arthritis Patient Penetration Rate (2015-2020E)
The US Rheumatoid Arthritis Anti-TNF Population (2015-2020E)
The US Rheumatoid Arthritis Biologics Population (2015-2020E)
Global Female Population (2010-2015)
Increasing Global Ageing Population of 60 Years or Older (2000-2030E)
Global Healthcare Expenditure (2009-2015E)
Increasing Cigarette Consumption (1910-2014)
Increasing Obese Population (2010-2015E)
Rheumatoid Arthritis Drug Prices (2013-2016E)
Rheumatoid Arthritis Market Share by Company (2015/2020E)
The US Rheumatoid Arthritis Brand (Company) Share (2016E)
Abbvie Revenue Share by Pharmaceutical Products (2015)
Abbvie Revenue Share by Region (2015)
Abbvie Revenue and Net Income (2012-2015)
Abbvie Research and Development Expenditure (2015)
Johnson & Johnson Revenue by Segment (2015)
Johnson & Johnson Revenue and Net Income (2012-2015)
Amgen Revenue Share by Products (2015)
Amgen Revenue and Net Income (2012-2015)
Pfizer Inc. Revenue by Segment (2015)
Pfizer Inc. Revenue and Net Income (2012-2015)

List of Tables

Development Progress of Anti-IL-6 Drugs for RA (2015)
Rheumatoid Arthritis Drug Approval and Developments (2015)
Use of Complementary and Alternative Medicines (2015)
Clinical Development of Biosimilars in Rheumatoid Arthritis (2015)
Global Rheumatoid Arthritis Competition by Biologics (2015)
New Products of Pfizer with FDA Approval (2015/2016)
New Innovative Product Portfolio of Johnson & Johnson (2015)
New Products of Pfizer with FDA Approval (2015/2016)